Avenue Therapeutics, Inc.
(NASDAQ : ATXI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.51%43.770.9%$908.31m
JNJJohnson & Johnson
1.51%135.970.6%$847.49m
MRKMerck & Co., Inc.
2.19%70.980.6%$587.27m
LLYEli Lilly and Company
0.21%110.851.0%$521.10m
ABBVAbbVie, Inc.
2.56%91.462.2%$505.43m
BMYBristol-Myers Squibb Company
0.05%57.641.4%$345.49m
NVSNovartis AG Sponsored ADR
2.80%85.480.2%$176.56m
AZNAstraZeneca PLC Sponsored ADR
4.11%39.011.3%$145.10m
GSKGlaxoSmithKline plc Sponsored ADR
2.21%39.740.2%$87.66m
NVONovo Nordisk A/S Sponsored ADR Class B
2.38%43.310.1%$87.09m
SNYSanofi Sponsored ADR
2.06%44.330.2%$60.10m
LCILannett Company, Inc.
2.74%4.1237.0%$7.06m
AKTXAkari Therapeutics Plc Sponsored ADR
2.97%1.831.7%$0.16m
EPIXESSA Pharma Inc
-6.03%3.430.1%$0.04m

Company Profile

Avenue Therapeutics, Inc. operates as a pharmaceutical company. It engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. The company was founded on February 9, 2015 and is headquartered in New York, NY.